Gemita Gemcitabine Injection 1400 Mg

Name: Gemita Gemcitabine Injection 1400 Mg
Brand: SURGICAL HUB
Price: 500 INR
Availability: InStock

Price 500 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

Gemita Gemcitabine Injection 1400 Mg Specification

Salt Composition
Gemcitabine 1400 mg

Indication
Pancreatic Cancer (Pancreatic Ca)

Dosage Form
Injection

Feature

Ingredients
Gemcitabine

Application
IV Infusion

Physical Color/Texture
Lyophilized powder

Storage Instructions
Store at 2-8C

Strength
1400 mg/35 ml

Route
IV Infusion

Packaging Size
Vial

Injection Type
Solution

Form
Injection

Prescription Required
Yes

Gemita Gemcitabine Injection 1400 Mg Trade Information

Minimum Order Quantity
10 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Vials Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About Gemita Gemcitabine Injection 1400 Mg

Gemita Gemcitabine Injection 1400 Mg is a best-seller among cytotoxic chemotherapy agents, renowned for its noteworthy efficacy in combating pancreatic cancer. Each vial contains an incomparable 1400 mg/35 ml sterile lyophilized powder, precision-formulated for IV infusion. Unlock the power of Gemcitabine, the paragon choice for oncology treatments, trusted widely across India by medical professionals and suppliers. With prescription-only access, this premier solution offers a reliable, stable dosage, and consistent results. Grab this essential solution-Gemita is an industry leader committed to patient well-being and clinical excellence.

Versatile Application in Oncology Treatment

Gemita Gemcitabine Injection 1400 Mg is primarily applied in the treatment of pancreatic cancer, serving as a trusted option in hospital oncology departments and specialized cancer centers. This solution is designed specifically for intravenous infusion, ensuring targeted delivery to the bloodstream. Its applicability extends to the surfaces of clinical settings, where strict medical administration protocols are observed. As a cytotoxic agent, Gemita is used under expert supervision, reinforcing its reputation for reliability and efficacy in cancer therapy.

Robust Supply, Timely Delivery, and Secure Packaging

Available for the domestic market and distributed by reputable suppliers and traders across India, Gemita Gemcitabine Injection is shipped with utmost care to preserve its potent formulation. Each vial is packaged securely, meeting stringent regulatory standards, and labeled for transparent valuation. Delivery times are optimized for quick turnaround, ensuring medical providers receive fresh stock promptly. Proper storage at 2-8C is advised to ensure quality retention, and every shipment reflects a commitment to the highest standards in pharmaceutical supply.

FAQ's of Gemita Gemcitabine Injection 1400 Mg:

Q: How is Gemita Gemcitabine Injection administered?

A: Gemita Gemcitabine Injection is administered intravenously as an IV infusion under the close supervision of qualified medical professionals in a clinical or hospital setting.

Q: What are the main indications for using Gemita Gemcitabine Injection 1400 Mg?

A: This injection is primarily indicated for the treatment of pancreatic cancer (Pancreatic Ca) and is a key component in advanced chemotherapy protocols.

Q: Where should Gemita Gemcitabine Injection be stored?

A: Gemita should be stored in a refrigerator at a temperature range of 2-8C to maintain its stability and effectiveness until use.

Q: When can I expect delivery after placing an order?

A: Delivery timelines are optimized for swift processing, and most domestic orders are shipped promptly to ensure the medication arrives in optimal condition and within the required timeframe.

Q: What packaging is used for Gemita Gemcitabine Injection shipments?

A: Each injection is supplied in a secure vial, accompanied by detailed labeling and protective packaging to comply with pharmaceutical safety regulations during transit.

Q: How does Gemita Gemcitabine benefit healthcare providers?

A: Healthcare providers benefit from Gemita's consistency, reliable dosing, and notable efficacy, making it a preferred choice for treating pancreatic cancer in specialized medical environments.

Tell us about your requirement